Pharmaceutical Pricing in Europe

Tiivistelmä

How are medicine prices decided upon in European countries? Which challenges do policy makers face? Which role do reimbursement aspects play in the pricing process? Are there communalities and similarities between European countries? This chapter provides information on pharmaceutical pricing policies in 30 European countries, including all 28 European Union Member States. Key pricing policies at ex-factory price level as well as in the supply chain will be presented. Medicine price data will be provided as an illustrative snapshort.

Tekijät

Sabine Vogler, Jaana E Martikainen 

Lisätietoja julkaisusta

• Avoin saatavuus: ei.
• Koko viite: Vogler, S., & Martikainen, J. E. (2015). Pharmaceutical Pricing in Europe. Teoksessa ZUD. Babar (toim.). Pharmaceutical Prices in the 21st Century (s. 343–370). Springer. https://doi.org/10.1007/978-3-319-12169-7_19